Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
insights from industryDr. Andrew DaviesApplications SpecialistSpecac Ltd. In this interview, AZoM talks to Dr. Andrew Davies, an applications specialist at Specac Ltd., about Specac and their FTIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback